Literature DB >> 19488079

Migraine: Telcagepant provides new hope for people with migraine.

Lars Edvinsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19488079     DOI： 10.1038/nrneurol.2009.49

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.

Authors:  Lars Edvinsson; Rikard Alm; Duncan Shaw; Ruth Z Rutledge; Kenneth S Koblan; Jenny Longmore; Stefanie A Kane
Journal:  Eur J Pharmacol       Date:  2002-01-02       Impact factor: 4.432

2.  Calcitonin gene-related peptide: functional role in cerebrovascular regulation.

Authors:  J McCulloch; R Uddman; T A Kingman; L Edvinsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Authors:  M D Ferrari; K I Roon; R B Lipton; P J Goadsby
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

4.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

5.  Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.

Authors:  Lars Edvinsson; Erik Uddman; Angelica Wackenfors; Anthony Davenport; Jenny Longmore; Malin Malmsjö
Journal:  Clin Sci (Lond)       Date:  2005-09       Impact factor: 6.124

6.  Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis.

Authors:  Christopher P Regan; Gary L Stump; Stefanie A Kane; Joseph J Lynch
Journal:  J Pharmacol Exp Ther       Date:  2008-11-07       Impact factor: 4.030

7.  Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.

Authors:  T W Ho; L K Mannix; X Fan; C Assaid; C Furtek; C J Jones; C R Lines; A M Rapoport
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

8.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

9.  Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.

Authors:  Tony W Ho; Michel D Ferrari; David W Dodick; Vince Galet; James Kost; Xiaoyin Fan; Heather Leibensperger; Samar Froman; Christopher Assaid; Christopher Lines; Hille Koppen; Paul K Winner
Journal:  Lancet       Date:  2008-11-25       Impact factor: 79.321

10.  Central projections of the sensory innervation of the rat middle meningeal artery.

Authors:  Yi Liu; Jonas Broman; Lars Edvinsson
Journal:  Brain Res       Date:  2008-03-07       Impact factor: 3.252
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.